Study of Tramadol Addiction Impact on Dental Anesthesia Success Among Algerian Males
NCT ID: NCT05418504
Last Updated: 2022-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
400 participants
INTERVENTIONAL
2022-05-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Tramadol is an FDA-approved medication for pain relief indicated mainly for moderate to severe pain, it is an opioid with 6 hours Half-Life and different dosages as 50mg, 100mg, 200mg and 300mg. Due to possible abuse and addiction potential, limitations to its use should be for pain that is refractive to other pain medication, such as non-opioid pain medication, unfortunately, the almost non-existent of censorship in Algeria and the disorderly framing made the obtain of tramadol as a medicine very easy which has led to a very alarming abuse of this drug
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Preoperative Oral Tramadol on Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis
NCT04961268
The Effects of Tramadol Combined With Local Anesthesia on Pain After the Surgical Extraction of Third Molars
NCT05614440
Use of Tramadol Intraligamentary Injections
NCT05538052
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.
NCT04812860
Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery
NCT01920386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non- Tramadol
the control group represented by dental patients who are not a tramadol addict
Dental anesthesia
Dental anesthesia, used to do any dental procedure
Tramadol
The study group with patients seeking dental service but also are tramadol addict.
Dental anesthesia
Dental anesthesia, used to do any dental procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dental anesthesia
Dental anesthesia, used to do any dental procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years
* With no comorbid conditions (HTN, Diabetes \& Epilepsy)
* Tramadol addict (regular tramadol user)
Exclusion Criteria
* ˂ 18 years
* With comorbid conditions (HTN, Diabetes \& Epilepsy)
* ≥ 65 years males
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Future University in Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doaa Mohamed Salah ElDin Diab ELBohy
Assisstant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Doaa MS El-Bohy, PhD
Role: PRINCIPAL_INVESTIGATOR
FUE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Doaa El-Bohy
Cairo, , Egypt
Future University in egypt
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Doaa El-Bohy, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-FOPFUE-16/119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.